2001

Aug 22, 2001
Nicky Spaulding Promoted to Guidant Management Committee as President, Cardiac Surgery

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) announced today that Nicky Spaulding has been promoted to the Guidant Management Committee as president of the...

Aug 20, 2001
Guidant Elaborates on its Distribution Agreement with COOK

Agreement Intended to Accelerate Time to Market and Complements Guidant's Drug-Coated Stent Program. Guidant Announces Live Webcast of its Drug-Coated Stent Briefing Indianapolis, Ind. - Guidant...

Aug 17, 2001
Guidant Receives Approval for Full Market Release of ANCURE System

Less-Invasive Therapy Available to Treat Patients with Abdominal Aortic Aneurysms Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Aug 17, 2001
Guidant Appoints Debra F. Minott as Vice President, General Counsel and Secretary

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Debra F. Minott, currently deputy general counsel and secretary, Guidant, has been promoted to vice president,...

Aug 15, 2001
First Patients Treated with Guidant's Next Generation Coronary Stent

Latest Stent Constructed of New Material Designed to Enhance Performance Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Aug 10, 2001
Appellate Court Decision Affirms the Strength of Guidant's Coronary Stent Patents

Indianapolis, Ind. - Guidant Corporation today stated that a recent U.S. Court of Appeals ruling on a coronary stent patent infringement suit affirms the strength of specific Guidant coronary...

Jul 24, 2001
Guidant Announces Worldwide Launch of New Self-Expanding Stent System

New Product Introduction Broadens Guidant's Global Line of Non-Coronary Therapies Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global...

Jul 18, 2001
Guidant Introduces its New Generation of Heart Failure Therapy

European Market Release of CONTAK RENEWAL, First Human Use Worldwide of CONTAK RENEWAL 2 Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European market...

Jul 17, 2001
Guidant Reports Second Quarter Sales of $656 Million

Earnings per share reach $0.38. Double-digit sales growth projected for the third and fourth quarters. Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for...

Jul 17, 2001
Physicians Resume Implants with Guidant's ANCURE System

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it has received an...

Show per page

Top